Subscribe to RSS
DOI: 10.1055/s-2008-1027195
© Georg Thieme Verlag KG Stuttgart · New York
Sonografische Leberdiagnostik bei Tumorpatienten ohne und mit Kontrastmittel
Baseline and Contrast-Enhanced Ultrasound of the Liver in Tumor PatientsPublication History
eingereicht: 7.6.2007
angenommen: 6.12.2007
Publication Date:
22 August 2008 (online)

Zusammenfassung
Die korrekte Detektion und Charakterisierung von Lebermetastasen ist wesentlich für die Therapieplanung bei Patienten mit einer malignen Grunderkrankung. Die Sensitivität des nativen Ultraschalls, der die am häufigsten genutzte Methode zum Leberstaging darstellt, ist im Vergleich zur kontrastmittelgestützten Computertomografie (CT) und Magnetresonanztomografie (MRT) deutlich geringer. Auch die korrekte Charakterisierung fokaler Leberläsionen mittels nativem Ultraschall (US) kann bei Tumorpatienten Schwierigkeiten bereiten. Lebermetastasen stellen sich nativ in der Mehrzahl echoarm dar. Probleme bereitet die Detektion von echogleichen und kleinen Metastasen. Durch den Einsatz von Ultraschallkontrastmitteln (USKM) und spezifischen Bildgebungstechniken konnte die Rolle des Ultraschalls in der Leberdiagnostik deutlich verbessert werden. Levovist und SonoVue sind die in Europa für die Leberdiagnostik zugelassenen Kontrastmittel (KM), wobei SonoVue durch die Möglichkeit der kontinuierlichen Untersuchung in Echtzeit Levovist weitestgehend in der Leberdiagnostik abgelöst hat. Essenziell für die Metastasendetektion sind die portalvenöse und die Spätphase, in denen Metastasen ein Auswaschen des KM zeigen und als echoarme KM-Aussparungen im homogen KM-angereicherten Leberparenchym abgrenzbar sind. Insgesamt konnte in mehreren Studien eine deutliche Sensitivitätssteigerung in der Lebermetastasendetektion durch den Einsatz von USKM nachgewiesen werden, in denen die Sensitivität des KMUS mit der KM-gestützten CT und MRT für die Leberdiagnostik vergleichbar sind. Die typischen Anreicherungsmuster der verschiedenen benignen und malignen Leberläsionen ermöglichen in der Regel auch eine sichere Charakterisierung und Differenzierung gegenüber Lebermetastasen. Dieser Artikel soll als Fortbildungsartikel einen Überblick über die Vorteile und den sinnvollen Einsatz von KM im Ultraschall vermitteln.
Abstract
In patients with known malignancy, correct detection and characterization of liver lesions has important therapeutic consequences. Conventional sonography is the most commonly used modality for liver imaging in tumor patients. However, it has a lower sensitivity for the detection of liver metastases compared to contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI). The majority of liver metastases are hypoechoic and well defined in baseline ultrasound (US), while detection of isoechoic or small liver metastases < 1 cm is difficult and the differentiation of liver metastases from benign liver lesions and other malignant liver tumors can be impossible with baseline US. The use of microbubble-based ultrasound contrast agents and contrast-specific imaging techniques advanced the accuracy of ultrasound in liver imaging. Levovist and SonoVue are the US contrast agents approved for liver imaging in Europe. Compared to Levovist, SonoVue allows continuous imaging of the liver in real-time over a period of up to 5 minutes. As a result, SonoVue became the preferred contrast agent for liver imaging in the recent years, while Levovist became less important. Important for the detection of liver metastases are the portal venous and late phases in which metastases show a wash-out and can be detected as hypoechoic lesions in homogeneous enhanced liver parenchyma. The detection of hepatic metastases is substantially improved by CEUS compared to conventional B-mode sonography. Several studies showed sensitivity in detecting liver metastases comparable to that of contrast-enhanced CT and MRI. Furthermore, the typical enhancement patterns of the different benign and malignant liver lesions allow reliable characterization and differentiation from liver metastases in the majority of cases. This paper provides information about the advantages and expedient application of contrast-enhanced ultrasound (CEUS) in tumor patients.
Key words
microbubbles - metastases - ultrasound
Literatur
- 1 Edmunson H, Craig J. Neoplasms of the liver. Schiff L Diseases of the liver Philadelphia; Lippincott 1987 8 ed: 1109
MissingFormLabel
- 2
Karhunen P J.
Benign hepatic tumours and tumour like conditions in men.
J Clin Pathol.
1986;
39
183-188
MissingFormLabel
- 3
Jones E C, Chezmar J L, Nelson R C. et al .
The frequency and significance of small (less than or equal to 15 mm) hepatic lesions
detected by CT.
Am J Roentgenol.
1992;
158
535-539
MissingFormLabel
- 4
Kreft B, Pauleit D, Bachmann R. et al .
Häufigkeit und Bedeutung von kleinen fokalen Leberläsionen.
Fortschr Röntgenstr.
2001;
173
424-429
MissingFormLabel
- 5
Ishak K G, Rabin L.
Benign tumors of the liver.
Med Clin North Am.
1975;
59
995-1013
MissingFormLabel
- 6
Wanless I R, Albrecht S, Bilbao J. et al .
Multiple focal nodular hyperplasia of the liver associated with vascular malformations
of various organs and neoplasia of the brain: a new syndrome.
Mod Pathol.
1989;
2
456-462
MissingFormLabel
- 7
Harvey C J, Albrecht T.
Ultrasound of focal liver lesions.
Eur Radiol.
2001;
11
1578-1593
MissingFormLabel
- 8
Hohmann J, Skrok J, Puls R. et al .
Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound
and SonoVue.
Fortschr Röntgenstr.
2003;
175
835-843
MissingFormLabel
- 9 Schonland M M, Milward-Sadler G H. et al .Hepatic tumours. Wright R, Alberti KG, Karran S, Milward-Sadler GH Liver and biliary diseases London; Saunders 919
MissingFormLabel
- 10
Wernecke K, Vassallo P, Bick U. et al .
The distinction between benign and malignant tumors and sonography: value of a hypoechoic
halo.
AJR.
1992;
159
1005-1009
MissingFormLabel
- 11
Clarke M P, Kane R A, Steele G . et al .
Prospective comparison of preoperative imaging and intraoperative ultrasonography
in the detection of liver tumors.
Surgery.
1989;
106
849-855
MissingFormLabel
- 12
Wernecke Jr K, Rummeny E, Bongartz G. et al .
Detection of hepatic masses in patients with carcinoma: comparative sensitivities
of sonography, CT, and MR imaging.
Am J Roentgenol.
1991;
157
731-739
MissingFormLabel
- 13
Ohlsson B, Tranberg K G, Lundstedt C. et al .
Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory
and imaging methods.
Eur J Surg.
1993;
159
275-281
MissingFormLabel
- 14
Albrecht T, Hoffmann C, Schmitz S. et al .
Detection of liver metastases: comparison of contrast-enhanced phase inversion ultrasound
and dual phase spiral CT with intraoperative sonographic correlation.
Radiology.
2000;
207 (P)
459
MissingFormLabel
- 15
Konopke R, Kersting S, Saeger H D. et al .
Detection of liver lesions by contrast-enhanced ultrasound – comparison to intraoperative
findings.
Ultraschall in Med.
2005;
26
107-113
MissingFormLabel
- 16
Albrecht T, Blomley M, Bolondi L. et al .
Guidelines for the use of contrast agents in ultrasound. January 2004.
Ultraschall in Med.
2004;
25
249-256
MissingFormLabel
- 17
Dietrich C F, Ignee A, Trojan J. et al .
Improved characterisation of histologically proven liver tumours by contrast enhanced
ultrasonography during the portal venous and specific late phase of SHU 508A.
Gut.
2004;
53
401-405
MissingFormLabel
- 18
Strobel D, Raeker S, Martus P. et al .
Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography
for the characterization of focal liver lesions.
Int J Colorectal Dis.
2003;
18
63-72
MissingFormLabel
- 19
Quaia E, Calliada F, Bertolotto M. et al .
Characterization of focal liver lesions with contrast-specific US modes and a sulfur
hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Radiology.
2004;
232
420-430
MissingFormLabel
- 20
Albrecht T, Hoffmann C W, Schmitz S A. et al .
Phase-inversion sonography during the liver-specific late phase of contrast enhancement:
improved detection of liver metastases.
Am J Roentgenol.
2001;
176
1191-1198
MissingFormLabel
- 21
Albrecht T, Blomley M J, Burns P N. et al .
Improved detection of hepatic metastases with pulse-inversion US during the liver-specific
phase of SHU 508A: multicenter study.
Radiology.
2003;
227
361-370
MissingFormLabel
- 22
Oldenburg A, Hohmann J, Foert E. et al .
Detection of hepatic metastases with low MI real time contrast enhanced sonography
and SonoVue.
Ultraschall in Med.
2005;
26
277-284
MissingFormLabel
- 23
Bernatik T, Becker D, Neureiter D. et al .
Detection of liver metastases – comparison of contrast – enhanced ultrasound using
first versus second generation contrast agents.
Ultraschall in Med.
2003;
24
175-179
MissingFormLabel
- 24
Blakeborough A, Ward J, Wilson D. et al .
Hepatic lesion detection at MR imaging: a comparative study with four sequences.
Radiology.
1997;
203
759-765
MissingFormLabel
- 25
Soyer P, Levesque M, Caudron C. et al .
MRI of liver metastases from colorectal cancer vs. CT during arterial portography.
J Comput Assist Tomogr.
1993;
17
67-74
MissingFormLabel
- 26
Valls C, Andia E, Sanchez A. et al .
Hepatic metastases from colorectal cancer: preoperative detection and assessment of
resectability with helical CT.
Radiology.
2001;
218
55-60
MissingFormLabel
- 27
Ward J, Naik K S, Guthrie J A. et al .
Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic
iron oxide with dual-phase CT by using alternative-free response receiver operating
characteristic analysis.
Radiology.
1999;
210
459-466
MissingFormLabel
- 28
Srivastava D N, Mahajan A. et al .
Colour Doppler flow imaging of focal hepatic lesions.
Australasian Radiology.
2000;
44
285-289
MissingFormLabel
- 29
Wang Y, Wang W P. et al .
Resistance index in differential diagnosis of liver lesions by color doppler ultrasonography.
World J Gastroenterol.
2004;
10
965-967
MissingFormLabel
- 30
Gonzales-Anon M, Cervera-Deval J, Garcia-Vila J H. et al .
Characterization of solid liver lesions with color and pulsed Doppler imaging.
Abdominal Imaging.
1999;
24
137-143
MissingFormLabel
- 31
Liang P, Cao B, Wang Y. et al .
Differential diagnosis of hepatic cystic lesions with gray-scale and color doppler
sonography.
Journal of Clinical Ultrasound.
2005;
33
100-105
MissingFormLabel
- 32
Lencioni R, Donati F, Cioni D. et al .
Detection of colorectal liver metastases: prospective comparison of unenhanced and
ferumoxides-enhanced magnetic resonance imaging at 1.5T, dual-phase spiral CT, and
spiral CT during arterial portography.
MAGMA.
1998;
7
76-87
MissingFormLabel
- 33
Ward J, Chen F, Guthrie J A. et al .
Hepatic lesion detection after superparamagnetic iron oxid enhancement: comparison
of five T 2-weighted sequences at 1.0T by using alternative-free response receiver
operating characteristic analysis.
Radiology.
2000;
214
159-166
MissingFormLabel
- 34
Dietrich C F, Kratzer W, Strobel D. et al .
Assessment of metastatic liver disease in patients with primary extrahepatic tumors
by contrast-enhanced sonography versus CT and MRI.
World J Gastroenterol.
2006;
12
1699-1705
MissingFormLabel
- 35
Bartolozzi C, Donati F, Cioni D. et al .
Detection of colorectal liver metastases: a prospective multicenter trial comparing
unenhanced MRI, MnDPDP-enhanced MRI and spiral CT.
Eur Radiol.
2004;
14
14-20
MissingFormLabel
- 36
Regge D, Campanella D, Anselmetti G C. et al .
Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting
liver metastases from colorectal carcinoma.
Clinical Radiology.
2006;
61
338-347
MissingFormLabel
- 37
Rickes S, Ocran K, Schulze S. et al .
Evaluierung dopplersonographischer Kriterien zur Differenzialdiagnostik von hepatozellulären
Karzinomen und Regeneratknoten bei Leberzirrhose.
Ultraschall in Med.
2002;
23
83-90
MissingFormLabel
- 38
Strobel D, Kleinecke C, Hänsler J. et al .
Contrast-Enhanced Sonography of Hepatocellular Carcinomas – Correlation with Histological
Diffrerentiation.
Ultraschall in Med.
2005;
26
270-276
MissingFormLabel
- 39
Dietrich C F, Schuessler G, Trojan J. et al .
Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced
ultrasound.
The British Journal of Radiology.
2005;
78
704-707
MissingFormLabel
- 40
Bauditz J, Schade T, Wermke W.
Sonografische Diagnostik des hilären cholangiozellulären Karzinoms mittels Echosignalverstärker.
Ultraschall in Med.
2007;
28
161-167
MissingFormLabel
- 41
Caseiro-Alves F, Brito J, Araujo A E. et al .
Liver hemangioma: common and uncommon findings and how to improve the differential
diagnosis.
Eur Radiol.
2007;
17
1544-1554
MissingFormLabel
- 42
Vilgrain V, Boulos L, Vullierme M P. et al .
Imaging of Atypical Hemangiomas of the Liver with Pathologic Correlation.
RadioGraphics.
2000;
20
379-397
MissingFormLabel
- 43
Vilgrain V.
Focal nodular hyperplasia.
European Journal of Radiology.
2006;
58
236-245
MissingFormLabel
- 44
Bartolotta T V, Taibbi A, Galia M. et al .
Characterization of hypoechoic focal hepatic lesions in patients with fatty liver:
diagnostic performance and confidence of contrast-enhanced ultrasound.
Eur Radiol.
2007;
17
650-661
MissingFormLabel
- 45
Bleuzen A, Huang C, Olar M. et al .
Diagnostic Accuracy of Contrast-Enhanced Ultrasound in Focal Lesions of the Liver
Using Cadence Contrast Pulse Sequencing.
Ultraschall in Med.
2006;
27
40-48
MissingFormLabel
- 46
Bartolotta T V, Taibbi A, Galia M. et al .
Centrifugal (inside-out) enhancement of liver hemangiomas: A possible atypical appearance
on contrast-enhanced US.
Eur J Radiol.
2007;
in press
MissingFormLabel
- 47
Dietrich C F, Mertens J C, Braden B. et al .
Contrast-Enhanced Ultrasound of Histologically Proven Liver Hemangiomas.
Hepatology.
2007;
45
1139-1145
MissingFormLabel
- 48
Nguyen B, Flejou J F, Benoit T. et al .
Focal Noduar Hyperplasia of the Liver: A Comprehensive Study of 305 Lesions and Recognition
of New Histologic Forms.
American Journal of Surgical Pathology.
1999;
23
1441
MissingFormLabel
- 49
Rickes S, Ocran K W, Gerstenhauer G. et al .
Evaluation of Diagnostic Criteria for Liver Metastases of Adenocarcinomas and Neuroendocrine
Tumours at Conventional Ultrasound, Unenhanced Power Doppler Sonography and Echo-Enhanced
Ultrasound.
Dig Dis.
2004;
22
81-86
MissingFormLabel
- 50
Larsen L P, Rosenkilde M, Christensen H. et al .
The value of contrast enhanced ultrasonography in detection of liver metastases from
colorectal cancer: a prospective double-blinded study.
Eur J Radiol.
2007;
62
302-307
MissingFormLabel
Dr. Anja Oldenburg
Klinik und Hochschulambulanz für Radiologie und Nuklearmedizin, Charite, Campus Benjamin
Franklin
Hindenburgdamm 30
12200 Berlin
Phone: ++ 49/30/84 45 64 73 20
Fax: ++ 49/30/84 45 44 74
Email: anja.oldenburg@charite.de